GoodLab

Our Background

Our team is not from a pharmaceuticals background and we are proud of it.

It gives us a fresh perspective on a problem that is holding back the development of life saving medicines.

Before GoodLab we spent a decade in online marketing, specifically building consumer facing marketplaces. We found success in democratizing American’s access to legal help, matching those looking for legal help across 60+ different fields of law to either law firms or legal aid in their area.

And whilst you may know a lawyer, or know someone who can refer you to a lawyer, the same cannot be said of the majority of Americans, particularly lower socio-economic cohorts. It’s an awareness problem. And one we have come to specialize in solving.

How Does This Relate to
Clinical Trials?

Now take clinical trials;

5^%

Only 5% of Americans having ever participated in
a clinical trial1

85^%

of patients were either unaware or unsure that participation in a clinical trial was an option at the time of diagnosis

75^%

of these patients said they would have been willing to enroll had they known it was possible

There exists a very wide gap between American’s willingness to participate in a clinical trial and the actual participation rate. And with 86% of all clinical trials delayed due to patient recruitment shortfalls, we found an opportunity to solve both sides of the marketplace.

And just like the barriers to entry in the legal industry, Income inequality breeds health inequality

Wealth is directly related to the quality of medical care you receive – this includes access to information about clinical trials. GoodLab is building awareness about clinical trials to underserved populations.

Why Are We Different To Other Patient Recruitment Companies?

When we talk digital patient recruitment, 95% of the time we are talking about Facebook ads or existing databases. We all know Facebook's ad delivery system is very effective at delivering ads to the right people at the right time. They want their ads to be seen by the people who are most likely to click. But is this a good thing?

Over time Facebook is going to keep showing trials to users that have already shown interest in finding solutions to particular health condition, or have shown interest in clinical trials.

At GoodLab we aren’t looking for people who showed past interest in clinical trials, we are looking for the 75% of patients that didn’t even know a clinical trial was possible.

Leadership Team

GoodLab is part of a 200+ team based out of Sydney, Australia. The founding team at GoodLab
have over 30+ years of digital marketing experience across all consumer verticals.

Daniel Kochan
CEO

Dan is one of the founding partners of GoodLab - he has deep experience building consumer facing marketplaces across numerous verticals.

Dan’s mum is a senior research fellow with a particular focus on cognitive aging, decline and dementia. A family dinner a few years ago saw her complaining to Dan about how hard it was to find patients for her groundbreaking research. This planted the seed for what would eventually become GoodLab.

Samuel Hoysted
CTO

Sam is the second half of the founding team of GoodLab. He has a background in engineering and has been building marketplaces for close to a decade.

Sam partook in a fair few clinical studies during his time at university to fund some of his less than ideal lifestyle choices at the time. Building GoodLab is his way of coming back full circle to an industry that provided in his times of need.

Josh Golombick
COO

Josh brings a wide-ranging scope of experience to his role, having worked previously in investment banking, marketplaces and fintech.

Josh’s uncle, who lives in a remote town in South Africa, has an incredibly rare skin condition. He has really struggled to find the right clinical trial. By raising awareness of clinical trials he is hoping that others don’t find themselves in the position of his uncle.